Abstract
Fluoroquinolones are increasingly important for anti-tuberculosis (TB) treatment. Identifying fluoroquinolone resistance (FR) is essential. Using sequencing data from over 16 000 unselected isolates, this first English survey of FR, found it present in 1.4% overall and 23.9% of multidrug-resistant TB. Routine sequencing allows clinically-relevant resistance surveillance and should be widely adopted.
| Original language | English |
|---|---|
| Pages (from-to) | 660-662 |
| Number of pages | 3 |
| Journal | Clinical Infectious Diseases |
| Volume | 80 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 15 Mar 2025 |
Bibliographical note
Publisher Copyright:© The Author(s) 2024.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Mycobacterium tuberculosis
- drug therapy
- fluoroquinolone resistance
- whole-genome sequencing
Fingerprint
Dive into the research topics of 'Population-Level Frequency of Fluoroquinolone Resistance by Whole-Genome Sequencing Drug Predictions in Mycobacterium tuberculosis Complex Isolates in England From 2017 Through 2023'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver